Dr. Richard Isaacson, United States
November 26, 2021
What is the Alzheimer’s disease Assessment
Scale–Cognitive Subscale endpoint and what does it assess? Watch Dr. Richard Isaacson discuss the ADAS-Cog in Alzheimer’s clinical trials.
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.